These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11865440)

  • 1. Biotechnology and clinical trials.
    Siegel JP
    J Infect Dis; 2002 Feb; 185 Suppl 1():S52-7. PubMed ID: 11865440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASSENT-3: implications for future trial design and clinical practice.
    Van de Werf F
    Eur Heart J; 2002 Jun; 23(12):911-2. PubMed ID: 12069439
    [No Abstract]   [Full Text] [Related]  

  • 3. Results from clinical trials on ST-elevation myocardial infarction in a historic perspective with some pathophysiological aspects.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2003 Dec; 37(6):316-23. PubMed ID: 14668180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter by Lozano et al regarding article, "Adjunctive thrombectomy for acute myocardial infarction: a bayesian meta-analysis".
    Lozano I; Avanzas P; Rondan J
    Circ Cardiovasc Interv; 2010 Jun; 3(3):e8; author reply e9. PubMed ID: 20551391
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trials of gene/biotechnology products.
    Röthig HJ
    Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):539-44. PubMed ID: 7885081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMi's Conducting Clinical Trials in Europe.
    Jago C
    IDrugs; 2009 Dec; 12(12):754-9. PubMed ID: 19943216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prehospital Fibrinolysis in concert with rapid PCI. Clinical trial shows promising results for use of clot-dissolving agents in the field.
    Persse DE; McCarthy JJ; Vooletich M; Richter BK; Anderson HV; Denktas AE; Sdringola SM; Smalling RW
    JEMS; 2008 Mar; 33(3):74-88. PubMed ID: 18328399
    [No Abstract]   [Full Text] [Related]  

  • 8. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25).
    Antman EM; Morrow DA; McCabe CH; Jiang F; White HD; Fox KA; Sharma D; Chew P; Braunwald E;
    Am Heart J; 2005 Feb; 149(2):217-26. PubMed ID: 15846258
    [No Abstract]   [Full Text] [Related]  

  • 9. [Protein C--a new opening in the treatment of sepsis syndrome].
    Petäjä J; Heikinheimo M
    Duodecim; 2002; 118(12):1217-9. PubMed ID: 12239812
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bolus fibrinolysis in acute myocardial infarction].
    Zeymer U
    Dtsch Med Wochenschr; 2002 Oct; 127(40):2083-6. PubMed ID: 12373644
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intravenous thrombolytic therapy in myocardial infarction (review)].
    Staroverov II
    Ter Arkh; 2003; 75(10):80-3. PubMed ID: 14669614
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene symbol: OTC. Disease: ornithine carbamoyltransferase deficiency.
    Hwu WL; Huang YT; Chien YH; Yeh HY; Lu F; Chou SP; Lin JM; Chiang SC
    Hum Genet; 2003 Sep; 113(4):367. PubMed ID: 12974280
    [No Abstract]   [Full Text] [Related]  

  • 13. Difficulties in performing clinical trials of antithrombotic therapy in neonates and children.
    Massicotte MP; Sofronas M; deVeber G
    Thromb Res; 2006; 118(1):153-63. PubMed ID: 16009401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.
    Kandzari DE
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S29-37. PubMed ID: 17224888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency.
    Wilson JM
    Mol Genet Metab; 2009 Apr; 96(4):151-7. PubMed ID: 19211285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
    Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M
    Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and conduct of clinical trials in systemic sepsis. Critical analysis of VA Cooperative Study No. 209.
    Shatney CH
    Prog Clin Biol Res; 1988; 264():71-80. PubMed ID: 3289037
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological reperfusion in acute myocardial infarction after ASSENT 3 and GUSTO V.
    Ferreira D
    Rev Port Cardiol; 2003; 22(7-8):1005-9. PubMed ID: 14587168
    [No Abstract]   [Full Text] [Related]  

  • 19. Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial.
    Sabatine MS; McCabe CH; Gibson CM; Cannon CP
    Am Heart J; 2005 Feb; 149(2):227-33. PubMed ID: 15846259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethical and practical issues in conducting clinical trials in psoriasis and psoriatic arthritis.
    Kavanaugh A
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii46-8. PubMed ID: 15708936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.